Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1738]
News [4523]
Articles [207]
Editorials [9]
Conferences [164]
elearning [24]
Editor's Choice for December 2016
Prof Gordon McVie - Editor in Chief, ecancer
Editor's Choice for December 2016 ( Prof Gordon McVie - Editor in Chief, ecancer )
20 Dec 2016
Combining radiotherapy with immunotherapy
Dr James Welsh - MD Anderson Cancer Center, Houston, USA
Combining radiotherapy with immunotherapy ( Dr James Welsh - MD Anderson Cancer Center, Houston, USA )
20 Dec 2016
A phase III study of buparlisib and fulvestrant in HR positive advanced breast...
Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA
A phase III study of buparlisib and fulvestrant in HR positive advanced breast cancer ( Dr Ruth O'Regan - University of Wisconsin-Madison, Madison, USA )
14 Dec 2016
Comparison between standard and reduced volume radiotherapy in bladder...
Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt
Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )
13 Dec 2016
Breast cancer mortality declining globally
Dr Cécile Pizot - International Prevention Research Institute, Lyon, France
Breast cancer mortality declining globally ( Dr Cécile Pizot - International Prevention Research Institute, Lyon, France )
9 Dec 2016
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin...
Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA
Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016
How can we use crenolanib to treat AML?
Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA
How can we use crenolanib to treat AML? ( Dr Eunice Wang - Roswell Park Cancer Institute, New York, USA )
5 Dec 2016
Thromboembolytic risks of central venous catheters in paediatric patients
Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA
Thromboembolytic risks of central venous catheters in paediatric patients ( Dr Julie Jaffray - Children's Center for Cancer, Los Angeles, USA )
5 Dec 2016
ALL: Combining paediatric-type therapy with minimal residual disease
Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
ALL: Combining paediatric-type therapy with minimal residual disease ( Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy )
5 Dec 2016
ASH 2016: AML, CLL and leukaemogenesis latest
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Intravenous or subcutaenous rituximab for FL in the SABRINA study
Dr Andrew Davies - University of Southampton, Southampton, UK
Intravenous or subcutaenous rituximab for FL in the SABRINA study ( Dr Andrew Davies - University of Southampton, Southampton, UK )
4 Dec 2016
Updates from the EURO-SKI trial of tyrosine kinase cessation
Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France
Updates from the EURO-SKI trial of tyrosine kinase cessation ( Dr Francois-Xavier Mahon - Université Bordeaux, Bordeaux, France )
3 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation